Prosensa Therapeutics wins the Most Innovative European Biotech SME Award 2011
On 8 November, at the EuropaBio event entitled "Biotechnology: what's in it for you", hosted at the European Parliament by Julie Girling, MEP, Prosensa Therapeutics was revealed as this year's winner of EuropaBio’s Most Innovative European Biotech SME Award. The winning SME fought off stiff competition from 26 other applicants from across the EU, all of which demonstrated ground-breaking research in the field of biotechnology in its healthcare, agricultural and industrial applications.
|
9:30 |
Registration |
|
|
10:00 |
Welcome and Introduction |
Ms Nathalie Moll, Secretary General of EuropaBio Ms Julie Girling, Member of the European Parliament |
|
10:10 |
Company highlights: Prof. Helga Rübsamen-Schaeff, CEO Aicuris GmbH & Co. KG |
|
|
10:20 |
Company highlights: Monika Kavaliauske, Marketing Manager Biocentras |
|
|
10:30 |
Company highlights: Christian Homsy, CEO Cardio3 Biosciences |
|
|
10:40 |
Company highlights: Hans Schickan, CEO Prosensa Therapeutics |
|
|
10:50 |
||
|
11:00 |
Q&A |
|
|
11:15 |
Biotech: looking back to see ahead |
G. Steven Burrill, Founder and CEO, Burrill & Company
|
|
11:45 |
EU innovation-related initiatives in favour of SMEs |
M Daniel Calleja-Crespo, Deputy Director General, DG Industry and Entrepreneurship and EU Commission SME Envoy |
|
12:00 |
SME Award presentation |
G. Steven Burrill, Daniel Calleja-Crespo, Tom Saylor and Nathalie Moll to present |
|
12:10 |
Speech by the Award winner |
|
|
12:20 |
Closing remarks |
Tom Saylor, CEO of Arecor and Chair of EuropaBio’s SME Platform |
